These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 20173718)

  • 21. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW; Cho WI; Lee CK; Seo SJ
    Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection.
    No YA; Ahn BH; Kim BJ; Kim MN; Hong CK
    J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy.
    Ahn KY; Kim ST
    Plast Reconstr Surg; 2007 Nov; 120(6):1662-1666. PubMed ID: 18040203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter.
    Kaya B; Apaydin N; Loukas M; Tubbs RS
    J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1663-8. PubMed ID: 25175271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement.
    Kim HJ; Yum KW; Lee SS; Heo MS; Seo K
    Dermatol Surg; 2003 May; 29(5):484-9. PubMed ID: 12752515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do repetitive botulinum neurotoxin injections induce muscle fibrosis? Sonographic observation of the masseter muscle.
    Koo HJ; Hu H; Kim W; Kim JS; Kim HJ; Yi KH
    J Cosmet Dermatol; 2024 Feb; 23(2):434-440. PubMed ID: 37942679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intramuscular nerve distribution of the masseter muscle as a basis for botulinum toxin injection.
    Kim DH; Hong HS; Won SY; Kim HJ; Hu KS; Choi JH; Kim HJ
    J Craniofac Surg; 2010 Mar; 21(2):588-91. PubMed ID: 20489458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commentary: The effect of botulinum toxin type A injection on lower facial contouring evaluated using a three-dimensional laser scan.
    Ahn KY
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2167. PubMed ID: 21244566
    [No Abstract]   [Full Text] [Related]  

  • 29. A Pilot Study on the Treatment of Posterior Cheek Enlargement in HIV+ Patients With Botulinum Toxin A.
    Scali C; Carruthers A; Malpas D; Humphrey S
    Dermatol Surg; 2015 Nov; 41(11):1300-8. PubMed ID: 26469200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of botulinum toxin type A in aesthetic mandibular contouring.
    Kim NH; Chung JH; Park RH; Park JB
    Plast Reconstr Surg; 2005 Mar; 115(3):919-30. PubMed ID: 15731696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower facial contouring with botulinum toxin type A.
    Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
    J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abobotulinum toxin A and onabotulinum toxin A for masseteric hypertrophy: a split-face study in 25 Korean patients.
    Lee SH; Wee SH; Kim HJ; Yeo UC; Lee NH; Lee SW; Cho SB
    J Dermatolog Treat; 2013 Apr; 24(2):133-6. PubMed ID: 21888570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasonographic Considerations for Safe and Efficient Botulinum Neurotoxin Injection in Masseteric Hypertrophy.
    Lee HJ; Jung SJ; Kim ST; Kim HJ
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33406757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects.
    Quezada-Gaon N; Wortsman X; Peñaloza O; Carrasco JE
    J Cosmet Dermatol; 2016 Sep; 15(3):238-44. PubMed ID: 26799545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemodenervation with botulinumtoxin in masseteric hypertrophy].
    Mischkowski RA; Siessegger M; Lazar F; Zöller JE
    Mund Kiefer Gesichtschir; 2005 Mar; 9(2):101-8. PubMed ID: 15711991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anatomical Considerations When Treating Compensatory Hypertrophy of the Upper Part of the Masseter after Long-Term Botulinum Neurotoxin Type A Injections.
    Lee KL; Cho HJ; Bae H; Park HJ; Park MS; Kim HJ
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32235784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiologic change and facial contour following botulinum toxin A injection in square faces.
    Lee CJ; Kim SG; Kim YJ; Han JY; Choi SH; Lee SI
    Plast Reconstr Surg; 2007 Sep; 120(3):769-778. PubMed ID: 17700130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A comparative study of botulinum toxin A and denervation-induced masseter muscle atrophy in rabbits].
    Liu HM; Zhao H
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2380-3. PubMed ID: 20965852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin A treatment for contouring of the lower leg.
    Han KH; Joo YH; Moon SE; Kim KH
    J Dermatolog Treat; 2006; 17(4):250-4. PubMed ID: 16971324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonging the duration of masseter muscle reduction by adjusting the masticatory movements after the treatment of masseter muscle hypertrophy with botulinum toxin type a injection.
    Wei J; Xu H; Dong J; Li Q; Dai C
    Dermatol Surg; 2015 Jan; 41 Suppl 1():S101-9. PubMed ID: 25548838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.